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Objective: Symptomatic knee osteoarthritis (OA) is poorly correlated with radiographic severity, but
subchondral bone measures may be useful for risk assessment as bone shape is grossly unaffected at
early radiographic stages. We sought to determine whether compartment-speciﬁc size mismatch in the
naturally asymmetric tibiofemoral joint, measured as tibiofemoral subchondral surface ratio (SSR): (1)
predicts incident symptoms, (2) predicts incident or progressive OA, (3) is reproducible and time
invariant.
Design: OA Initiative participants with baseline MRIs and up to 48-month follow-up (n ¼ 1,338) were
analyzed. Logistic regression was used to determine the association between SSR and incident symp-
toms, incident OA, and progression of OA after adjusting for demographic, radiologic, injury-related, and
lifestyle-related factors. Reproducibility was assessed as % coefﬁcient of variation (CV) on repeat MRI
studies at baseline and 24 months.
Results: Increased medial SSR is protective against incident symptoms at 48 months (per 0.1 increase: OR
0.48 CI 0.30, 0.75; P ¼ 0.001). Increased lateral SSR values are protective against lateral OA incidence (OR
0.23 CI 0.06, 0.77; P ¼ 0.016) or progression (OR 0.66 CI 0.43, 0.99; P ¼ 0.049) at 24 months. Both medial
and lateral SSR are stable over time (medial: mean change 0.001 SD 0.016; lateral: mean change 0.000 SD
0.017) and are highly reproducible (3.0% CV medial SSR; 2.7% CV lateral SSR).
Conclusions: A larger medial SSR is protective against developing OA-related symptoms. A larger lateral
SSR is protective against lateral OA incidence or progression. Finally, lateral and medial SSR are stable
over time and are highly reproducible across MRI studies.
 2014 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Knee osteoarthritis (OA) is common in the United States, with an
estimated 37% prevalence of radiographic OA among adults over
age 601. Knee OA is a multifactorial disease process and many risk
factors have been identiﬁed including obesity2, age1, genetics3,4
sex4, race4, tobacco use5,6 comorbid joint diseases7, trauma8, and: D.C. Flanigan, OSU Sports
Columbus, OH 43221, USA.
. Everhart), Siston.1@osu.edu
).
ternational. Published by Elsevier Lknee alignment9. Biomechanical factors that lead to excessive joint
loading such as obesity2, hip-knee-ankle alignment9,10 and
frequent squatting or kneeling11 cause mechanical wear of articular
cartilage with a corresponding chronic inﬂammatory response12,13.
Obesity is also associated with knee symptoms14,15, with a corre-
sponding decrease in symptom severity after weight loss14,16.
Identiﬁcation of patients anatomically predisposed to devel-
oping symptomatic OA would provide an opportunity for the clini-
cian to counsel patients to minimize lifestyle related OA risk factors
and potentially delay or prevent symptom onset. In particular,
measurements of based on subchondral contourwould be useful for
risk assessment as asymptomatic patients often already have sig-
niﬁcant cartilage loss at the time of evaluation17,18 The tibiofemoral
joint is naturally asymmetric, and this results in an intrinsic degreetd. All rights reserved.
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within each compartment. Recent knee morphology research sug-
gests that subchondral bone shape is actually quite variable across
individuals. Mahfouz et al. in their principal components analyses of
a large sample of computed tomography (CT)-derived knee sub-
chondral surface models found signiﬁcant individual, sex, and race-
speciﬁc variation in distal femur and proximal tibial shape and
size.19 In contrast with the well-studied relationship between knee
alignment andOA, very little is known about the role of subchondral
bone shape in OA pathogenesis or progression. Speciﬁcally, no
researchhas been conducted todetermine the relationship between
subchondral size mismatch and radiographic or symptomatic OA. It
is also unknownwhethermore subtle variations in subchondral size
mismatch occur over time in knees that are non-arthritic or are at
early stages of OA.
This study was designed to address these gaps in knowledge by
determining whether degree of compartment-speciﬁc asymmetry,
measured as the tibiofemoral subchondral surface ratio (SSR): (1) is
predictive of incident symptoms; (2) is predictive of incident or
progressive OA; (3) covaries with time or OA progression. We hy-
pothesize that tibiofemoral SSR is associated with OA incidence,
progression, and symptoms. We also hypothesize that, with the
exception of knees with severe radiographic changes including
subchondral surface deformation, tibiofemoral SSR is a stable
metric, which remains constant over time.
Methods
Data sources and patient selection
The OA Initiative (OAI) is an NIH-funded, multi-center, observa-
tional cohort study focused on knee OA. The study protocol, amend-
ments, and informed consent documentation were reviewed and
approved by the Institutional Review Boards at all participating sites.
A total of 4,796 participants ages 45e79 were recruited to either an
incidence or progression subcohort. Participants in the progression
subcohort had both frequent knee symptoms and radiographic signs
of OA in at least one native knee at baseline. Participants in the inci-
dence subcohort were either asymptomatic and/or did not have
radiographic signs of OA in either knee at baseline; however, all
participants in the incidence subcohortwere required to have at least
one OA risk factor (frequent symptoms, overweight, history of knee
injury or surgery, history of total knee replacement in parent or sib-
ling, Heberden’s nodes present on hands, frequent repetitive knee
bending, or age 70e79). Data used in the preparation of this article
were obtained from the OAI database, which is available for public
access at http://www.oai.ucsf.edu/. Speciﬁc datasets used are the
clinical datasets for baseline (version 0.2.2), 24months (version 3.2.1)
and 48 months (version 6.2.1) in addition to magnetic resonance
imaging (MRI) datasets (Eckstein group) for baseline (version 0.5), 24
months (version 3.5), and 48 months (version 6.4). This study was
conducted without the review of the OAI Publications Committee of
its scientiﬁc content and data interpretation.
We utilized a convenience sample of all participants in the OA
Initiative who had a baseline knee MRI that was quantitatively
assessed by a single vendor (Chondrometrics, Gmbh, Ainring; Par-
celsus University, Salzburg) (n ¼ 1,338 patients; n ¼ 685 progres-
sion cohort, n ¼ 653 incidence subcohort). To ensure all
observations were independent, we utilized one knee per patient
only (1,338 patients, 251 left knees, 1,087 right knees). Of the 96
patients with bilateral knee MRIs, we selected the knee with the
most complete follow-up radiologic data or at random when
similar data were available. No further inclusion or exclusion
criteria were applied. At baseline, the mean age of this sample was
62.4  9.2 years, 40.4% (n ¼ 579) were male, 59.6% (n ¼ 854) werefemale, 80.0% (n ¼ 1,146) were Caucasian, 17.3% (n ¼ 248) were
African-American, and 61.6% (n ¼ 884) were symptomatic. The
majority of participants had OA at baseline (n¼ 987, 68.9% Kellgren
and Lawrence (KL) grades 2e3, n ¼ 66, 4.6% KL grade 4), though a
substantive minority of patients had no radiographic OA (n ¼ 380,
26.5% KL grades 0e1).
MRI assessment and measurement of SSR
All patients underwent 3.0 T knee MRIs at baseline and a subset
of patients also underwent serial MRIs at 2 years (n ¼ 745) and 4
years (n ¼ 86) follow-up. Articular cartilage segmenting of all knee
MRIs was performed on either a coronal fast lowangle shot (FLASH)
water excitation (WE) sequence (1.5 mm slice thickness; echo time
(TE) 7.57 ms, repetition time (TR) 20 ms; in-plane resolution
0.31mm 0.31mm; acquisition time 8min, 30 s) or sagittal double
echo steady state (DESS) WE sequence (0.7 mm slice thickness; TE
4.7 ms, TR 16.3 ms, in-plane resolution 0.37 mm  0.46 mm,
acquisition time 10 min 23 s)20. All knee MRIs were quantitatively
assessed by a single vendor (Chondrometrics, Gmbh, Ainring; Par-
celsus University, Salzburg); detailed descriptions of the measure-
ment methods are reported by Eckstein et al. and Wirth et al.21,22.
Articular surface area, subchondral surface area, and average
cartilage thickness of the medial and lateral compartments re-
ported by the vendor were utilized in this analysis. Regions of
denuded cartilage were included in the subchondral surface area
but not the articular surface area or cartilage thickness measure-
ments. Osteophytes and cartilage overlying osteophytes were not
included in any of these measurements. All measurements were
extracted directly from the OAI database.
The tibiofemoral SSR was deﬁned as the weight-bearing femoral
subchondral surface area divided by the tibial subchondral surface
area; the study authors utilized the subchondral surface measures
from the OAI database to calculate this ratio for both medial and
lateral compartments and for the entire tibiofemoral joint. The
weight-bearing portion of the femoral condyle was deﬁned in the
sagittal DESS sequence as 60% of the surface between the trochlear
notch (anteriorly) and the posterior end of the femoral condyles
[Fig. 1]23. This was deﬁned in the coronal FLASH sequence as the
entire subchondral condylar surface in 60% of slices visualizing the
condyle when starting at the trochlear notch (the anteriormost slice
with divergence of the trochlea into the femoral condyles) and
advancing posteriorly to include the last slice demonstrating the
circular structure of the posterior condyle (both bone and cartilage)
of the compartment being measured23. The tibial subchondral sur-
face areawas determined by segmentation of the entire subchondral
and articular surfaces of the respective plateaus; this included por-
tions of the subchondral surface completely denuded of overlying
cartilage and did not include osteophytes. The twomethods (sagittal
DESS or coronal FLASH) were shown by Eckstein et al. to be reliably
interchangeable23. For sagittal DESS, there is high reported repro-
ducibility of measurements in all tibibial and femoral regions for
subchondral surface area (RMS coefﬁcient of variation (CV)% range
2.6% for medial tibia to 9.2% for lateral tibia), cartilage surface area
(CV 2.9%medial tibia to 9.1% lateral tibia), and cartilage thickness (CV
2.3% medial tibia to 4.5% medial femur)23. High reproducibility has
also been reported for coronal FLASH WE for subchondral bone (CV
2.8% for medial tibia to 5.4% for medial femur), cartilage surface area
(CV 2.9% medial tibia to 5.9% medial femur), and cartilage thickness
(CV 3.0% medial tibia to 3.8% medial femur).23
Clinical assessments
Demographic and medical history data from the baseline study
questionnaires and self-reported knee symptom-related data were
Fig. 1. Segmentation of the weight-bearing femoral condyle in a sagittal sequence. The
weight-bearing region is deﬁned as 60% of the subchondral surface between the
trochlear notch (anterior white line) and the posterior end of the femoral condyles.
Note that the anterior white line is oriented parallel to the femoral shaft and through
the trochlear notch in a central slice between the medial and lateral femoral condyles
(not in the slice shown here). The posterior ends of the medial and lateral formal
condyles are determined by the slice depicting the most posterior aspects of the
respective condyles. The SSR is deﬁned as the weight-bearing femoral condylar surface
area divided by the subchondral surface area of the corresponding tibial plateau.
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Age, weight, body mass index (BMI), lifetime smoking status (self-
reported use of at least 100 cigarettes in one’s entire life), current
smoking status, and lifetime pack-year history were collected at the
time of study enrollment. The overall activity level of participants in
the sample was assessed by the Physical Activity Scale for the
Elderly (PASE)24. History of ipsilateral knee injury was deﬁned by
report of an injury severe enough to limit walking ability for at least
2 days. History of knee surgery was deﬁned by report of any
arthroscopic or open surgical procedure on the ipsilateral knee.
Finally, though anterior knee symptomswere not a primary focus of
the OAI we recognize that patellofemoral involvement can
contribute to knee OA symptoms and disability in general25e27 and
collected information on presence of patellofemoral crepitus or a
positive patellofemoral grind test at the time of the baseline clinical
evaluation to be able to control for this potential confounder in our
analysis.
The same deﬁnition for symptom status was used in this anal-
ysis as was used for OAI study enrollment (OAI method). Specif-
ically, baseline symptomatic status is deﬁned by self-reported knee
pain, aching or stiffness more than half the days of a month within
the past year. Incident knee symptoms was deﬁned as an increased
frequency of symptoms from less than half of days in any given
month during the year preceding the baseline visit to greater than
half days of any given month in the past year at follow-up included
in these deﬁnitions.Fig. 2. Boxplot of medial SSR values from baseline MRI by KL OA grade at study
enrollment. Moderately arthritic knees (KL grades 2 and 3; denoted by double asterisk
**) have signiﬁcantly higher medial SSR values than non-arthritic (KL grades 0 and 1)
and severely arthritic (grade 4) knees (denoted by single asterisk *) (P < 0.001, Tukeye
Kramer honestly signiﬁcant difference (HSD)).Radiographic assessments
All OAI radiographs and radiologic assessments were obtained
using a standardized protocol; all measurements were extracted
directly from the OAI database. Brieﬂy, serial bilateral knee radio-
graphs were obtained with a standard ﬁxed-ﬂexion posterior-
anterior (PA) view and a KL grade28 for OA severity was assigned by
two independent reviewers with an established adjudicationprocess for discrepant scores. OA severity in individual compart-
ment was categorized by OARSI osteophyte grade.29
OA was deﬁned by either (1) a KL grade 2 at baseline for the
entire joint, or (2) OARSI grade 1 for individual compartments.
Incident OA was deﬁned by either (1) a change from KL grade from
<2 at baseline to2 at follow-up for the entire joint, or (2) a change
in OARSI grade from <1 at baseline to 1 at follow-up for an in-
dividual compartment. Finally, progressive OA was deﬁned as (1)
any increase in KL grade for the entire joint, or (2) an increase in
Osteoarthritis Research Society International (OARSI) grade or a
deﬁnite increase in joint space narrowing as determined by the
reviewer for an individual compartment. Fixed ﬂexion PA radio-
graphs were also used to quantitatively assess joint space width
(JSW) at speciﬁc locations along the joint line with a validated
protocol described in detail by Neumann et al.30 Joint widths at the
0.200 and 0.800 coordinates were used to characterize medial and
lateral JSW due to high cross-sectional and longitudinal reliability
within the OAI study. Finally, as malalignment is a known risk factor
for OA progression9,31, data on degree of valgus or varus were also
utilized; these measures were obtained on full-limb radiographs
with a standard protocol32.
Statistical analysis
Descriptive data and univariate analysis
All statistical tests were performed with a standard software
package (JMP 9.0.3, SAS institute, Cary, NC). No published data
regarding SSRs were available at the time of study design to
perform an a priori power analysis, and we therefore relied on
convenience sampling methods. Descriptive statistics were ﬁrst
generated for demographic, clinical, and radiologic factors after
stratifying by baseline symptom status. Baseline differences in SSR
by OA and symptom status were determined by two-tailed Stu-
dent’s t-tests and one-way analysis of variance (ANOVA). As ex-
pected, KL-grade 4 knees had gross changes in subchondral contour
with a mean SSR that differed signiﬁcantly from moderately
arthritic knees (KL grades 2 and 3; P < 0.001) [Fig. 2]; therefore,
grade 4 knees at baseline (n ¼ 66) were excluded from further
Table I
Demographics, symptom scores, medical history, and radiologic measures stratiﬁed
by symptom status
Symptomatic
(n ¼ 797)
count (%)
Asymptomatic
(n ¼ 540)
count (%)
P-value
Female 453 (56.8%) 335 (62.0%) 0.069
Male 344 (43.2%) 205 (37.9%)
Prior injury 316 (39.7%) 132 (24.8%) <0.001
Prior surgery 213 (26.8%) 57 (10.6%) <0.001
African-American 185 (23.2%) 43 (8.0%) <0.001
Caucasian 586 (73.5%) 489 (90.6%)
Other race 26 (3.3%) 8 (1.5%)
Ever smoker 429 (45.6%) 228 (42.0%) 0.15
Current smoker 54 (6.8%) 31 (5.8%) 0.61
Valgus knee alignment
(3 valgus)
371 (46.8%) 199 (43.9%) 0.35
Varus knee alignment
(3 varus)
225 (28.4%) 130 (28.7%)
Neutral alignment
(<3 from neutral)
197 (24.8%) 124 (27.4)
Radiographic OA absent
(KL grades 0 & 1)
112 (14.1%) 264 (48.9%) <0.0001
Radiographic OA present
(KL grades 2 & 3)
645 (80.9%) 256 (47.4%)
Radiographic OA present
(KL grade 4)
40 (5.0%) 20 (3.7%)
Incident OA (KL grade 2)
at 48 m
23 (23.0%) 19 (8.2%) 0.0004
Incident medial OA
(OARSI grade 1) at 48 m
20 (7.3%) 7 (2.4%) 0.004
Incident lateral OA
(OARSI grade 1) at 48 m
11 (2.1%) 5 (1.2%) 0.23
Progression of KL grade at 48 m 197 (28.4%) 76 (16%) 0.0024
Progression of medial OARSI
grade at 48 m
182 (26.9%) 51 (11.0%) <0.0001
Progression of lateral OARSI
grade at 48 m
91 (13.9%) 25 (5.4%) <0.0001
Mean (SD) Mean (SD)
Age (years) 62.4 (8.9) 62.7 (9.7) 0.539
BMI 30.2 (4.9) 27.8 (4.7) <0.0001
Weight (kg) 86.1 (16.1) 77.9 (15.4) <0.0001
Smoking pack-year history 0 (IQR 0e15) 0 (IQR 0e8) 0.009
PASE score 163.7 (82.8) 156.5 (73.8) 0.12
Femur total subchondral
SA (cm2)
12.43 (2.08) 11.99 (1.90) 0.0007
Femur medial subchondral
SA (cm2)
6.07 (1.05) 5.75 (0.94) <0.0001
Femur lateral subchondral
SA (cm2)
6.37 (1.12) 6.24 (1.02) 0.08
Tibia total subchondral
SA (cm2)
21.89 (3.73) 21.93 (3.67) 0.43
Tibia medial subchondral
SA (cm2)
11.49 (2.04) 11.86 (1.97) <0.0001
Tibia lateral subchondral
SA (cm2)
10.40 (1.91) 10.07 (1.85) 0.007
SSR-total joint 0.572 (0.059) 0.550 (0.050) <0.0001
Medial SSR 0.534 (0.074) 0.488 (0.053) <0.0001
Lateral SSR 0.617 (0.067) 0.625 (0.065) 0.04
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symptoms, incident OA, and progressive OA were then determined
by simple logistic regression analysis (maximum likelihoodmethod
for model ﬁtting; P-values reported from likelihood-ratio tests).
Multivariate analysis
Several logistic regression models were created to determine
the independent association between medial and lateral SSR and
incident symptoms, incident radiographic OA, or progression of
radiographic OA at 24 and 48 months. Potential covariates in the
models included age, BMI, sex, race, knee injury and surgery his-
tory, tobacco use, physical activity level (PASE score), KL and OARSI
grades, OA-related symptom status, patellofemoral crepitus or
positive patellar grind test, medial and lateral joint width, average
cartilage thickness, and joint alignment. To control for confounding
between SSR and the outcome of interest, all factors were indi-
vidually assessed for inclusion in eachmodel and added if inclusion
resulted in a 10% change or greater in the standardized coefﬁcient
for either medial or lateral SSR. This “change in estimate” criterion
is a common epidemiologic method to select for important con-
founders while minimizing variability of the estimated effect of
interest by avoiding entry of unnecessary variables into the
model.33,34
Time invariance and precision (reproducibility) of SSR
The mean change in SSR was determined between MRIs per-
formed at baseline, 24 months and 48 months. Linear regression
models were created to determine independent predictors of
change in SSR (as a continuous variable only) by 24 and 48 months.
Among knees that did not progress to KL grade 4, precision
(reproducibility) was assessed between baseline and 24-month
MRIs (n ¼ 745) as the root mean square (RMS) coefﬁcient of vari-
ation percentage (CV %) and the Pearson correlation coefﬁcient.
Knee MRIs performed at 48 months were not utilized for reliability
due to small sample size (n ¼ 86).
Results
Descriptive data and univariate analyses
Participants who were symptomatic at baseline were more
likely to have a history of prior injury (39.7% vs 24.8%; P  0.001)
or prior surgery (26.8% vs 10.6%; P < 0.001), had a higher average
BMI (30.2 vs 27.8; P < 0.001), and were more likely to have
radiographic signs of OA (85.9% KL grade 2 or higher vs 51.1%;
P < 0.001) (Table I). Symptomatic patients at baseline also had a
9.6% larger medial SSR (0.534 vs 0.488; P < 0.001). After stratiﬁ-
cation by OA status, medial SSR was larger among symptomatic
participants with OA (KL grades 2 and 3) by 10.6% (5.462 vs 4.937;
P < 0.001) but was not signiﬁcantly larger among symptomatic
participants without OA (KL grades 0 and 1) (4.876 vs 4.813; 1.6%
difference, P ¼ 0.30).
In the simple (unadjusted) models (Table II), each 0.1 unit in-
crease in medial SSR was associated with a higher risk of medial OA
progression (odds ratio (OR) 1.43 CI 1.15, 1.77; P ¼ 0.0015) and
lateral OA progression (OR 1.87, CI 1.44, 2.42; P < 0.001) at 48
months but a lower risk of incident symptoms (OR 0.58 CI 0.39,
0.84; P ¼ 0.0035). Conversely, each 0.1 unit increase in lateral SSR
was associated with a lower risk of incident lateral OA at 24months
(OR 0.29 CI 0.09, 0.83; P ¼ 0.021) or 48 months (OR 0.43 CI 0.17,
0.98; P ¼ 0.04) but not OA progression or incident symptoms at
either time point (P > 0.25).Multivariate analysis
In the fully adjusted models (Table III), each 0.1 unit increase in
medial SSR resulted in a signiﬁcant reduction in risk of developing
symptoms at 24 months (odds ratio (OR) 0.50 conﬁdence interval
(CI) 0.31, 0.78; P ¼ 0.002) or 48 months (OR 0.48 CI 0.30, 0.75;
P ¼ 0.001). Increased medial SSR was also associated with a
reduction in medial OA incidence at 48 months (OR 0.51 CI 0.24,
0.98; P ¼ 0.042) with a trend toward signiﬁcance at 24 months (OR
0.54 CI 0.23, 1.15; P ¼ 0.11). Conversely, each 0.1 unit increase in
lateral SSR was associated with lower risk of lateral OA incidence
and lateral OA progression; this relationship was statistically sig-
niﬁcant at 24 months (incidence: OR 0.23 CI 0.06, 0.77 P ¼ 0.016;
Table II
Unadjusted odds of radiographic OA incidence & progression and OA-related
symptom incidence at 24 and 48 months due to SSR
Medial SSR
(continuous value)
Lateral SSR
(continuous value)
Unadjusted odds
ratio*
P-value Unadjusted
odds ratio*
P-value
24 Monthsy
OA incidence 1.11 (0.54, 2.15) 0.77 0.50 (0.24, 0.96) 0.038
Medial OA incidence 0.74 (0.34, 1.48) 0.42 0.76 (0.36, 1.57) 0.47
Lateral OA incidence 1.11 (0.45, 2.42) 0.81 0.29 (0.09, 0.83) 0.021
OA progression 1.18 (0.94, 1.47) 0.15 0.87 (0.68, 1.12) 0.29
Medial OA progression 1.43 (1.15, 1.77) 0.0015 1.07 (0.84, 1.36) 0.30
Lateral OA progression 11.76 (1.33, 2.32) <0.0001 0.86 (0.61, 1.20) 0.37
Incident symptoms 0.69 (0.47, 1.00) 0.05 1.07 (0.76, 1.52) 0.67
48 Monthsy
OA incidence 1.28 (0.71, 2.23) 0.40 0.74 (0.42, 1.29) 0.29
Medial OA incidence 0.62 (0.31, 1.13) 0.12 0.68 (0.35, 1.25) 0.22
Lateral OA incidence 0.85 (0.38, 1.74) 0.67 0.43 (0.17, 0.98) 0.04
OA progression 1.27 (1.04, 1.54) 0.016 0.98 (0.80, 1.21) 0.87
Medial OA progression 1.43 (1.17, 1.75) 0.0005 1.00 (0.80, 1.24) 0.99
Lateral OA progression 1.87 (1.44, 2.42) <0.0001 0.97 (0.72, 1.29) 0.84
Incident symptoms 0.58 (0.39, 0.84) 0.0035 0.93 (0.66, 1.30) 0.67
* Reported as odds per 0.1 unit increase in SSR.
y KL grade 4 knees were excluded as a signiﬁcant difference in surface area ratios
were observed between moderately arthritic (grades 2 and 3) and severely arthritic
(grade 4) knees [Fig. 2] which we believe is due to deformity of bone contour (an
explicit criterion for grade 4 designation)17.
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signiﬁcance and similar effect size at 48months (incidence: OR 0.45
CI 0.16, 1.18 P ¼ 0.11; progression: OR 0.70 CI 0.46, 1.05 P ¼ 0.08).
Finally, a sensitivity analysis was performed for varying cutoff
values for medial SSR in relation to risk of incident symptoms
(Table IV). A consistent 40e60% reduction in risk of developing
frequent symptoms by 24 or 48 months was among participants
with higher medial SSR values when a cutoff of 0.450e0.600 was
utilized. Though anterior knee symptoms are a potential contrib-
utor to overall symptoms of knee OA25e27, in the current study
there was no signiﬁcant effect of anterior knee symptoms on theTable III
Adjusted odds of radiographic OA incidence & progression and OA-related symptom
incidence at 24 and 48 months due to SSR
Medial SSR
(continuous value)
Lateral SSR
(continuous value)
Adjusted odds
ratio*,z
P-value Adjusted odds
ratio*,z
P-value
24 Months
OA incidence 1.75 (0.80, 3.70) 0.15 0.45 (0.19, 0.99) 0.048
Medial OA incidence 0.54 (0.23, 1.15) 0.11 1.16 (0.50, 2.56) 0.73
Lateral OA incidence 1.85 (0.65, 4.71) 0.23 0.23 (0.06, 0.77) 0.016
OA progressiony 0.79 (0.59, 1.06) 0.14 0.80 (0.60, 1.07) 0.14
Medial OA progression 1.01 (0.74, 1.37) 0.93 0.88 (0.64, 1.22) 0.44
Lateral OA progressiony 1.25 (0.84, 1.86) 0.27 0.66 (0.43, 0.99) 0.049
Incident symptomsy 0.50 (0.31, 0.78) 0.0021 1.36 (0.91, 2.01) 0.13
48 Months
OA incidence 1.66 (0.79, 3.36) 0.18 0.59 (0.28, 1.21) 0.15
Medial OA incidence 0.51 (0.24, 0.98) 0.042 1.03 (0.51, 2.04) 0.91
Lateral OA incidence 1.14 (0.45, 2.71) 0.77 0.45 (0.16, 1.18) 0.11
OA progression 0.91 (0.55, 1.24) 0.44 0.89 (0.69, 1.14) 0.34
Medial OA progression 1.04 (0.78, 1.40) 0.77 0.87 (0.65, 1.17) 0.35
Lateral OA progressiony 1.34 (0.88, 2.03) 0.17 0.70 (0.46, 1.05) 0.08
Incident symptomsy 0.48 (0.30, 0.75) 0.0009 1.27 (0.86, 1.88) 0.19
Bold represents statistically signiﬁcant result.
* Reported as odds per 0.1 unit increase in SSR.
y KL grade 4 knees were excluded as a signiﬁcant difference in surface area ratios
were observed between moderately arthritic (grades 2 and 3) and severely arthritic
(grade 4) knees [Fig. 2] which we believe is due to deformity of bone contour (an
explicit criterion for grade 4 designation)17.
z After adjusting for sex, race, age, BMI, tobacco use, activity level, knee coronal
alignment, baseline symptoms, injury history, surgery history, KL grade, and JSW.relationship between SSR and frequent OA symptoms and no
adjustment for either patellofemoral crepitus on patellar grind was
required in any model.33,34
Time invariance and precision (reproducibility) of SSR
There is very little variability in medial or lateral SSR over time
among subjects with KL grade 0e3 knees. At 24 months, the mean
changes in SSR were close to zero for both medial (mean change
0.001  0.016 standard error of measurement (SEM) 0.001) and
lateral compartments (mean change 0.000  0.019 SEM 0.001)
(Table V) a similarly small mean change was observed between SSR
at baseline and 48 months for both medial (mean change
0.002  0.017 SEM 0.002) and lateral compartments (mean change
0.001  0.015 SEM 0.002). Other than progression to KL grade 4
(P < 0.001), there were no signiﬁcant predictors of change in SSR at
24 months or 48 months (P > 0.25 for all factors). Finally, among
participants who did not progress to KL grade 4, there was very
high reproducibility between SSR measurements obtained from
MRIs performed at baseline and 24months; therewas an estimated
3.0% CV (root mean squared error (RMSE) 0.0155; Pearson’s
r ¼ 0.978) for medial SSR and 2.7% CV (RMSE 0.0167; Pearson’s
r ¼ 0.970) for lateral SSR.
Discussion
Symptomatic knee OA is a major cause of morbidity in the
elderly. A large body of research is devoted to prediction and pre-
vention of radiographic OA; however, far fewer studies have been
published that focus on predicting symptoms, and the relationship
between symptom status and radiographic severity is poor17,18. The
motivation for this investigation was our hypothesis that SSR, a
measure of size mismatch between subchondral surfaces in the
naturally asymmetric tibiofemoral joint, would be predictive of
radiographic or symptomatic OA and be time-invariant. Our ﬁnd-
ings conﬁrm this hypothesis and address a critical gap in knowl-
edge by demonstrating that a relatively large weight-bearing
medial condylar surface relative to the medial plateau is an inde-
pendent predictor of future symptoms. This important ﬁnding al-
lows for more effective risk assessment for future symptoms, even
if early radiographic changes are present.
The ﬁndings from this study directly support utilization of
medial SSR as a clinical screening tool for future knee OA-related
symptoms in select patients. In particular, an increased medial
SSR is protective against development of future knee symptoms
among currently asymptomatic Caucasian and African American
patients over age 45 who do not have existing KL grade 4 OA. Given
recent advances in cartilaged-based MRI biomarkers of disease
activity such as T2 or T1rho mapping35e38, a screening MRI in pa-
tients at high risk for OAmay provide an opportunity to assess both
current disease activity and risk of developing knee symptoms.
Patients with modiﬁable OA risk factors such as frequent stair
climbing or obesity are particularly well-suited for a screening MRI,
as the clinician can counsel patients with a low medial SSR value
and high disease activity that lifestyle modiﬁcation to minimize
arthritis risk factors will be especially important to avoid future
knee symptoms. However, in order to facilitate use of SSR in a
clinical setting it will be necessary to determine an efﬁcient means
of approximating subchondral surface area. The technique utilized
to determine medial SSR values relies on manual segmentation
methods that are reproducible but could not be performed in a
basic image viewing software program21e23, whereas an approxi-
mating measure for condylar surface such as coronal width
multiplied by 60% of sagittal length could be performed in any
image viewer.
Table IV
Sensitivity analysis of medial compartment SSR as a risk factor for incident symptoms at 24 or 48 months
SSR >0.40 SSR >0.45 SSR >0.475 SSR >0.50 SSR >0.525 SSR >0.55 SSR >0.60
Incident symptoms 24 months
Adjusted odds ratio*,y 1.37 (0.38, 8.79) 0.42 (0.23, 0.790) 0.39 (0.22, 0.67) 0.59 (0.34, 0.99) 0.54 (0.30, 0.95) 0.47 (0.23, 0.89) 0.40 (0.12, 1.05)
P-value 0.67 0.0077 0.0008 0.0475 0.033 0.019 0.065
Incident symptoms 48 months
Adjusted odds ratio*,y 0.78 (0.24, 3.41) 0.40 (0.23, 0.73) 0.47 (0.29, 0.78) 0.59 (0.36, 0.98) 0.33 (0.17, 0.60) 0.48 (0.23, 0.92) 0.55 (0.19, 1.36)
P-value 0.71 0.0025 0.0036 0.0398 0.0002 0.0266 0.21
* KL grade 4 knees were excluded as a signiﬁcant difference in surface area ratios were observed betweenmoderately arthritic (grades 2 and 3) and severely arthritic (grade
4) knees [Fig. 2] which we believe is due to deformity of bone contour (an explicit criterion for grade 4 designation)17.
y After adjusting for sex, race, age, BMI, tobacco use, activity level, knee coronal alignment, baseline symptoms, injury history, surgery history, KL grade, and JSW.
J.S. Everhart et al. / Osteoarthritis and Cartilage 22 (2014) 771e778776The results of this study also demonstrate that race-speciﬁc
differences in SSR may account for some of the differences in
symptom prevalence and severity observed between Caucasians
and African-Americans39,40. However, even after adjustment in the
logistic regression model, African-American race remained a sig-
niﬁcant independent predictor of baseline symptom status relative
to Caucasians (OR 2.57 CI 1.68e4.00, P< 0.001). This may be related
to race-speciﬁc differences observed in the expression of several
genes implicated in OA pathophysiology4. Another possible expla-
nation for this persistent association is presented in a recent study
by Allen et al. in which the authors conclude that race-speciﬁc
differences in symptom status are largely attributable to factors
such as arthritis self-efﬁcacy and coping strategies41.
The association between lateral SSR and lateral compartment
OA progression is interesting, though this study is not appropriately
designed to establish a causal mechanism. However, these ﬁndings
do provide a context to guide future studies to further deﬁne the
relationship between lateral SSR and lateral OA. Similar to previous
studies demonstrating the relationship between knee valgus and
joint loading, the effect of lateral SSR on knee loading could be
tested in an animal model by directly measuring compressive
contact stress42 or in vivo by correlating lateral SSR with lateral
compartment tracer uptake and distribution pattern in bone
SPECT/CT43.
The time-invariance and high reproducibility of SSR across
multiple MRI studies in knees that remain below KL grade 4 is an
important ﬁnding, particularly in the context of utilizing SSR to
predict incident knee symptoms or KOA progression. As radio-
graphic severity is poorly correlated with symptom status17,18, it is
important to identify prognostic factors for future symptoms that
are insensitive to early radiologic changes. This was a major part of
our rationale for investigating subchondral size mismatch instead
of cartilage surface area mismatch as asymptomatic patients may
already have signiﬁcant cartilage loss at the time of evaluation17,18.
Similarly, radiologic measures are more useful as predictive tools if
they are independent of disease severity; while cartilage-based
measures are important biomarkers of disease activity,Table V
CV RMSE, mean difference (SD) and correlation for lateral SSR and medial SSR, be-
tween MRI studies at baseline and 24 months
Medial SSR Lateral SSR
Mean SSR e baseline 0.54283 0.6161
Mean SSR e 24 months 0.54403 0.6161
Mean difference (SD) 0.0012 (0.0157) 0.0000 (0.0168)
Minimum difference 0.0639 0.0819
Maximum difference 0.0634 0.0571
RMSE 0.0155 0.0167
RMSE CV% 2.7% 3.0%
Correlation coefﬁcient 0.978 0.970subchondral measures such as lateral SSR may predict risk of future
OA progression regardless of current severity. Finally, the stability
of medial SSR values over time suggests that utilization of previ-
ously acquired knee MRIs for unrelated complaints is an acceptable
cost-saving alternative to acquiring a new MRI for screening
purposes.
Use of secondary data from the OAI allowed us to account for
many relevant confounders in this investigation. In particular, the
association betweenmedial SSR and baseline or incident symptoms
was much stronger after adjustment for confounders than in the
unadjusted analysis. However, use of secondary data was also a
major limitation as the ﬁndings from this study may not be
generalizable to populations that are underrepresented in this
sample such as patients younger than 45 years and or who are not
Caucasian or African-American. Finally, though the methods for
obtaining the measures used to calculate SSR are validated and
reproducible with conventional MRI sequences21e23, the clinical
applicability of SSR screening to assess risk of future symptomsmay
be limited by the time burden of manual segmentation until a more
efﬁcient surrogate MRI or radiographic measure is established for
routine clinical use.
In conclusion, MRI-based screening for medial SSR in asymp-
tomatic Caucasian or African-American patients over 45 with KL
grade 0e3 knees is a valid assessment of future symptom risk.
Lateral SSR is an independent predictor of lateral OA progression,
and both lateral and medial SSR are time-invariant in KL grade 0e3
knees. Further research is recommended to identify and validate
simpliﬁed versions of SSR for clinical use and to determine the
causal mechanisms between medial SSR and knee symptoms or
lateral SSR and lateral OA progression.Contributions
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